Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018). (2019)
Attributed to:
Smart surveillance towards malaria elimination in Mpumalanga: novel approaches for mapping antimalarial resistance
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12936-019-2911-y
PubMed Identifier: 31438951
Publication URI: http://europepmc.org/abstract/MED/31438951
Type: Journal Article/Review
Volume: 18
Parent Publication: Malaria journal
Issue: 1
ISSN: 1475-2875